| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |

Laboratory of Molecular Carcinogenesis, National Institute of Environmental Health Sciences (NIEHS), Research Triangle Park, North Carolina 27709
Address all correspondence and requests for reprints to: Paul A. Wade, Ph.D., Laboratory of Molecular Carcinogenesis, National Institute of Environmental Health Sciences, P.O. Box 12233, 111 TW Alexander Drive, Research Triangle Park, North Carolina 27709. E-mail: wadep2{at}niehs.nih.gov.
The estrogen receptor (ER)-
(ESR1) is a key regulatory molecule in mammary epithelial cell development. Loss of ER-
in breast cancer is correlated with poor prognosis, increased recurrence after treatment, and an elevated incidence of metastasis. A proposed molecular pathway by which ER-
acts to constrain invasive growth in breast cancer cells involves direct, ER-
-dependent expression of metastasis-associated protein 3, a cell-type-specific component of the Mi-2/NuRD chromatin remodeling complex. MTA3 in turn represses expression of Snail, a transcription factor linked to epithelial to mesenchymal transition and cancer metastasis. To elucidate its role(s) in epithelial to mesenchymal transition (EMT), we expressed Snail in the noninvasive, ER-
-positive MCF-7 cell line. Snail expression led to decreased cell-cell adhesion and increased cell invasiveness. Furthermore, we observed loss of ER-
expression at both the RNA and protein level that was accompanied by direct interaction of Snail with regulatory DNA sequences at the ESR1 locus. A consequence of loss of ER-
function in this system was the increased abundance of key components of the TGF-β signaling pathway. Thus, cross-talk among ER-
, Snail, and the TGF-β pathway appears to control critical phenotypic properties of breast cancer cells.
NURSA Molecule Pages Link:
This article has been cited by other articles:
![]() |
S. J. Ellison-Zelski, N. M. Solodin, and E. T. Alarid Repression of ESR1 through Actions of Estrogen Receptor Alpha and Sin3A at the Proximal Promoter Mol. Cell. Biol., September 15, 2009; 29(18): 4949 - 4958. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Cardamone, C. Bardella, A. Gutierrez, L. Di Croce, M. G. Rosenfeld, M. F. Di Renzo, and M. De Bortoli ER{alpha} as ligand-independent activator of CDH-1 regulates determination and maintenance of epithelial morphology in breast cancer cells PNAS, May 5, 2009; 106(18): 7420 - 7425. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Palmer, P. Majumder, J. C. Cooper, H. Yoon, P. A. Wade, and J. M. Boss Yin Yang 1 Regulates the Expression of Snail through a Distal Enhancer Mol. Cancer Res., February 1, 2009; 7(2): 221 - 229. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Burd, H. K. Kinyamu, F. W. Miller, and T. K. Archer UV Radiation Regulates Mi-2 through Protein Translation and Stability J. Biol. Chem., December 12, 2008; 283(50): 34976 - 34982. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Dumont, M. B. Wilson, Y. G. Crawford, P. A. Reynolds, M. Sigaroudinia, and T. D. Tlsty Sustained induction of epithelial to mesenchymal transition activates DNA methylation of genes silenced in basal-like breast cancers PNAS, September 30, 2008; 105(39): 14867 - 14872. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |